Skip to main content
. Author manuscript; available in PMC: 2014 Nov 1.
Published in final edited form as: Cancer Gene Ther. 2013 Oct 25;20(11):630–637. doi: 10.1038/cgt.2013.58

Figure 3. Treatment with Y27632 causes increased measles virus induced cytopathic effect in vitro.

Figure 3

Figure 3

A. Cytopathic effect of MV-GFP on MDA-MB-231 and U251 at 0.01 MOI as determined by trypan blue exclusion assay alone or in combination with 150 µM or 25 µM respectively of Y27632. Y27632 alone was used as control. Combination of MV-GFP and Y27632 led to faster elimination of tumor cell monolayers when compared to either therapy alone.

B. Percent of cells surviving as determined by trypan blue exclusion assay on day 7 after incubation with MV-GFP concurrently treated with increasing concentrations of Y27632 as noted on the graph.